Does RUXOLITINIB Cause Product physical consistency issue? 103 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Product physical consistency issue have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.2% of all adverse event reports for RUXOLITINIB.
103
Reports of Product physical consistency issue with RUXOLITINIB
0.2%
of all RUXOLITINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product physical consistency issue From RUXOLITINIB?
Of the 103 reports, 1 (1.0%) required hospitalization.
Is Product physical consistency issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 103 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Product physical consistency issue?
LEUPROLIDE (926)
CLASCOTERONE (317)
BUPRENORPHINE (242)
MINOXIDIL (171)
CHOLESTYRAMINE (141)
NAPROXEN (117)
TESTOSTERONE (113)
DEVICE (85)
CLOBETASOL (76)
POLYETHYLENE GLYCOL 3350 (69)
Which RUXOLITINIB Alternatives Have Lower Product physical consistency issue Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE